CBRE Group Moves Up In Analyst Rankings, Passing Alexion Pharmaceuticals
February 11, 2019 at 11:46 AM EST
In a study of analyst recommendations at the major brokerages, for the underlying components of the S&P 500, CBRE Group Inc (CBRE) has taken over the #57 spot from Alexion Pharmaceuticals Inc. (ALXN), according to ETF Channel..